Insulet (PODD) Cash from Investing Activities Growth (3y) (2013 - 2026)
Insulet (PODD) Cash from Investing Activities Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 17.83% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | -6.23% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -24.52% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | -32.54% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -68.12% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 37.39% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -11.04% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 19.58% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -17.67% |
| 10 | Insulet | 10.27 Bn | 9.74 Bn | 562.60 Mn | -17.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -17.42% |
| Mar 31, 2026 | 13.02% |
| Dec 31, 2025 | -20.01% |
| Sep 30, 2025 | 2.94% |
| Jun 30, 2025 | -2.09% |
| Mar 31, 2025 | 30.71% |
| Dec 31, 2024 | -23.16% |
| Sep 30, 2024 | -33.92% |
| Jun 30, 2024 | -29.75% |
| Mar 31, 2024 | -1.87% |
| Dec 31, 2023 | 23.03% |
| Sep 30, 2023 | -118.07% |
| Jun 30, 2023 | -32.83% |
| Mar 31, 2023 | -72.60% |
| Dec 31, 2022 | -17.86% |
| Sep 30, 2022 | -68.44% |
| Jun 30, 2022 | 17.78% |
| Mar 31, 2022 | -101.42% |
| Dec 31, 2021 | 3.72% |
| Sep 30, 2021 | 22.90% |